Day: March 15, 2022

Junshi Biosciences and Coherus Announce Presentation of Positive Results from CHOICE-01, a Phase 3 Clinical Trial Evaluating Toripalimab in Combination with Chemotherapy as First-Line Treatment for Non-Small Cell Lung Cancer, at March ASCO Plenary Series

NervGen Pharma Receives Approval from Safety Review Committee to Proceed to Second Cohort in Multiple Ascending Dose Portion of Phase 1 Clinical Trial of NVG-291

The dose of NVG-291 in the first cohort is already above the highest corresponding dose that resulted in dramatic functional...

Sonendo, Inc. Hits New Milestone of 800,000 GentleWave® Procedures, Demonstrating Continued Adoption and Growing Preference for Less Invasive Alternative to Traditional Root Canal Therapy

Milestone achieved just 5 months after hitting the 700,000 milestone Company announces new investment in practice consultants to support onboarding,...

error: Content is protected !!